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tp://cBackground:Owing to the human-like physiology, aminipigmodel of nonalcoholic steatohepatitis (NASH) could
be valuable. Pigs, however, rarely develop substantial hepatic steatosis, even when fed diets with high fat, fruc-
tose, and cholesterol (FFC) content. The potential of choline-deficient, amino acid–defined high-fat diets
(CDAHFD) was therefore evaluated in G€ottingen Minipigs. Methods: Castrated male G€ottingen Minipigs were
fed either chow (n = 5) or one of the three NASH diets: FFC (n = 5), CDAHFD with sucrose (CDAHFD-S; n =
4), or fructose (CDAHFD-F; n = 4) for 8 weeks. Liver and blood samples were collected after 2 weeks and at termi-
nation. Results: Compared with chow, the body weight was higher after FFC (9.8 ± 0.4 versus 8.5 ± 1.2 kg;
mean ± SD) and less after CDAHFD-S (6.4 ± 0.8 kg) and CDAHFD-F (6.9 ± 0.8 kg). Liver weight per kg body weight
was significantly increased in all 3 NASH groups (FFC 2.1 times; and both CDAHFD diets 3.1 times). Histolog-
ically, pronounced macrovesicular steatosis developed only in the CDAHFD groups. Inflammation was present
in all three NASH groups. In the CDAHFD groups, inflammatory cells formed crown-like structures around stea-
totic hepatocytes. Sirius red staining revealedmild fibrosis in the two CDAHFD groups with the fibrotic potential
being further supported by immunohistochemical staining for activated stellate cells and gene expression ana-
lyses. No noticeable differences were found between CDAHFD-S and CDAHFD-F. Conclusions: G€ottingen Mini-
pigs fed CDAHFD developed pronounced steatosis with inflammation around steatotic hepatocytes and
incipient fibrosis, thereby showing potential as a model for human NASH. Further studies are needed to inves-
tigate the period needed for marked fibrosis to develop. ( J CLIN EXP HEPATOL 2020;10:211–221)N
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DNonalcoholic fatty liver disease (NAFLD) hasreached a global prevalence of 25%, with a signif-icant number of patients progressing to nonalco-
holic steatohepatitis (NASH) and potentially liver cirrhosis
and hepatocellular carcinoma.1 Histologically, the stron-
gest predictor of disease-specific mortality is the fibrosis
stage,2 and the approaches for finding effective treatments
for NASH include targeting the underlying metabolic dis-
ease, hepatic inflammation, and/or fibrosis.3,4 Good, trans-
lational animal models are instrumental for studying
disease mechanisms and for drug discovery.
Pigs are more similar to humans than rodents
regarding for instance metabolism, lipid profile, and in-s: Choline, Fatty liver, Fibrosis, Porcine, Animal model
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tions: NAFLD: non-alcoholic fatty liver disease; NASH: non-alco-
eatohepatitis; FFC: high-fat, fructose, cholesterol; CDAHFD:
deficient; amino acid defined high-fat diet (-S: with sucrose; -F:
ctose); EDTA: ethylenediaminetetraacetic acid; GLDH: glutamate
genase; HE: hematoxylin and eosin; CD45: cluster of differentia-
SMA: smooth muscle actin; ALT: alanine transaminase; AST:
e transaminase; ALP: alkaline phosphatase; GGT: gamma-gluta-
sferase
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Indian National Association for Study of the Liver. Published by Els
reativecommons.org/licenses/by-nc-nd/4.0/). Journal of Clinical andflammasome5 and are often used to model cardiovascular
diseases. Furthermore, the size allows repeated tissue and
blood sampling and the use of clinical diagnostic modal-
ities. Pigs, however, rarely develop substantial hepatic
steatosis, even after feeding a diet high in fat, fructose,
and cholesterol (FFC) for many months7–11—possibly
because the liver is not the primary site of de novo
lipogenesis in pigs.6 With regard to hepatic fibrosis, it is
generally limited and varying in degree after FFC diets
and tends to have a sinusoidal and periportal localiza-
tion.
In rodents, choline-deficient diets are often used to
induce NASH, and if factors such as the content of methi-
onine and lipids are optimally balanced, the appetite and
body weight (BW) of the animals can bemaintained, signif-
icant degrees of steatosis develop quickly, and marked
fibrosis can be obtained after a few months.12,13 Among
the most promising rodent diets is the choline-deficient,
L-amino acid–defined, high-fat diet (CDAHFD) with
approximately 0.1% methionine and a high content of
saturated fat.12,13 In mice, fructose in the diet leads to
more hepatic fatty acid synthesis and cytotoxicity
compared with glucose.14,15 In humans, the role of fructose
per se in disease progression is less clear,14,15 and it remains
to be addressed in pigs.evier B.V. This is an open access article under the CC BY-NC-ND license
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FLDMinipigs are attractive to use in long-term studies. The
G€ottingen Minipig is the smallest and best characterized
minipig and the one most commonly used in drug discov-
ery worldwide.18,19
The present study evaluated the potential of the
following three diets to induce NASH in G€ottingen Mini-
pigs as compared with chow: FFC diet and CDAHFD
with sucrose (CDAHFD-S) or fructose (CDAHFD-F).METHODS
Animals and housing
All experiments were approved by the Danish Animal Ex-
periments Inspectorate (license number: 2016-15-0201-
01078). Eighteen male G€ottingen Minipigs (Ellegaard
G€ottingen Minipigs, Dalmose, Denmark) were castrated
at 7 weeks of age and gradually switched to their respective
diets over the following week. Between 8 and 16 weeks of
age, they were fed one of four diets: chow (n = 5), FFC
diet (n = 5), CDAHFD-S (n = 4), or CDAHFD-F (n = 4).
They were housed in groups according to diet with straw
as bedding and had ad libitum access to fresh drinking wa-
ter. The room temperature was kept at 22–24 C and there
was access to a heating lamp. Lights were on between 6 a.m.
and 7 p.m. and the pigs were weighed twice weekly.Diets and feeding
All diets were produced by Special Diets Services
(Witham, United Kingdom): chow (Mini-Pig Expanded);
FFC diet, containing 2% cholesterol, 0.7% cholic acid,
18% fructose, 20% fat (hydrogenated soy oil, coconut oil
and lard), 0.07% choline and 0.35% methionine—match-
ing that used in other larger minipig studies focused on
NASH7–9; CDAHFD, containing 1% cholesterol, 0.35%
cholic acid, 30% fat (milk fat and cocoa butter), no
choline, 0.1% methionine, and either 20% sucrose
(CDAHFD-S) or 20% fructose (CDAHFD-F). The chow
group was fed according to internal standards (3–4% of
their BW per day), and the FFC group was fed the same
amount of food (on weight basis). These two groups ate
all the food offered. The CDAHFD groups were offered
approximately 75% of this amount of food (on weight
basis), i.e., an isocaloric amount relative to the chow
group. All pigs were fed twice daily, with access to the
food for up to 1 h each time. The minipigs in the two
CDAHFD groups had decreased appetite in the
beginning—a problem which was corrected over a 3- to
4-week period by adding various flavors to the diets,
ending with banana cream flavor (LorAnn Oils, Lansing,
MI, USA). Over the first 4 weeks, the percentages of
offered diet eaten weekly were 60, 83, 81, and 93 in the
CDAHFD-S group and 65, 82, 76, and 95 in the
CDAHFD-F group.212 © 2019 Indian National Association for Study of the Liver. Published byBlood and liver samples
After 2 and 8 weeks of diet feeding, blood samples were
taken from the jugular vein after an overnight fast. Af-
ter 2 weeks on diet, each animal was furthermore anes-
thetized (i.m. injection of a mixture containing
0.25 mg/kg of butorphanol and 1.25 mg/kg of each
of the following: tiletamine, zolazepam, ketamine, and
xylazine), and had a biopsy (approximately 2  2 cm)
surgically taken from the ventral edge of lobus hepatis
sinister medialis by using electrosurgery shears. Each bi-
opsy was quickly split into 3 parts, of which two were
snap frozen (in tubes placed in dry ice and thereafter
at 80 C) and one was put in formalin for 4 days at
4 C. At study end, the animals were fasted overnight,
deeply anesthetized as as mentioned previously and ex-
sanguinated. The liver was quickly taken out, weighed,
and photographed. Thereafter, a biopsy was taken
from the middle of each of the 4 liver lobes and placed
in formalin. In addition, from the middle of lobus hepatis
sinister medialis, 4 extra samples were taken: one placed
in formalin, two snap frozen on dry ice, and one placed
in RNA later.
Blood analyses
After 8 weeks on diet, a hematological analysis was per-
formed on ethylenediaminetetraacetic acid (EDTA) full
blood (Advia 2120i Hematology System, Siemens, Bal-
lerup, Denmark) and a clinical chemistry analysis was per-
formed on serum (Advia 1800 Chemistry System). In
addition, glucose, fructosamine, triglycerides, and gluta-
mate dehydrogenase (GLDH) were measured in EDTA
plasma on a Cobas 6000 autoanalyzer (Roche Diagnos-
tics GmbH, Mannheim, Germany). Insulin and glucagon
levels were measured by Luminescent Oxygen Channeling
Immunoassay as previously described,20 using GLU 1F120
mAb conjugated acceptor beads and biotinylated GLU 2F7
mAb for glucagon.
Biochemical analysis of liver tissue
The snap frozen liver samples (following both 2 and 8
weeks of diet feeding) were homogenized and treated as
previously described.21 The content of cholesterol and tri-
glycerides was measured on the Cobas 6000 autoana-
lyzer. For triglycerides, samples were recentrifuged after
thawing and the infranatant used for analysis.
Histology
Formalin fixed samples were processed by standard pro-
cedures and stained with hematoxylin and eosin (HE)
and picrosirius red. Immunohistochemistry for cluster of
differentiation 45 (CD45) and smooth muscle actin
(SMA) was performed on the automated Discovery Ultra
platform (Ventana Medical Systems, Roche, Switzerland).Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1 Body weight (A), liver gross morphology (B), liver weight (C), and relative liver weight (D) of the four different groups after 8 weeks of diet
feeding: chow (n = 5), FFC (high fat, fructose and cholesterol, n = 5), CDAHFD-S (n = 4), and CDAHFD-F (n = 3); the latter two groups being
choline-deficient, amino acid–defined high-fat diets with sucrose and fructose, respectively. Data in A are shown as mean  SEM. Scale bars in B
= 5 cm. In C and D, statistically significant differences from chow (**P < 0.01, ***P < 0.001, and ****P < 0.0001) and between other groups ($ P <
0.05, $$ P < 0.01) are indicated. CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with sucrose; CDAHFD-F, choline-deficient, amino
acid–defined high-fat diet with fructose.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
N
A
FL
DBriefly, deparaffinized sections were subjected to heat-
induced epitope retrieval using cell conditioning 1 me-
dium for 24 min at 95 C and blocking unspecific staining
with Tris-NaCl-blocking buffer. Monoclonal rabbit anti-
CD45 and the polyclonal rabbit anti-SMA antibodies
(ab10588 and ab5694 from Abcam) were applied at 1 mg/
mL for 1 h at 37 C. Antibody binding was detected with
Histofine anti-rabbit universal immuno-peroxidase poly-
mer (Nichirei Bioscience) and visualized with Purple chro-
mogen (Roche). Nuclei were counterstained with
hematoxylin. All stained sections were scanned at 20x us-
ing the NanoZoomer 2.0 HT system (Hamamatsu,
Glostrup, Denmark).
Morphometry was performed with Visiopharm Inte-
grator System (version 4.2.2.0, Visiopharm, Hoersholm,
Denmark) using the acquisition module and automated
image analysis, including automated tissue detection to
define regions of interest. Analyses for CD45, SMA, sirius
red, and nuclei were performed at 20x magnification with
the preprocessing step contrast red-green followed by
threshold analysis. Several postprocessing steps were per-
formed to numerate nuclei for ratio calculations. Quanti-
tative digital image analysis of steatosis was performed
on HE sections.Journal of Clinical and Experimental Hepatology | May–June 2020 | Vol. 10Gene expression analysis
RNAwas isolated from approximately 50mg of frozen liver
tissue using the RNeasy Mini Kit including DNAse treat-
ment (Qiagen, Hilden, Germany) following the manufac-
turer's instructions. Concentration and purity of the
RNA samples were measured in a Nanodrop ND-1000
spectrophotometer (NanoDrop technologies, Wilmington,
USA). RNA integrity was assessed visually with agarose gel
electrophoresis and in an Experion machine using the
RNA StdSens kit (BioRad, Denmark). All samples had an
RNA quality index between 8.9 and 10 (average = 9.4)
and were included for further processing.
Two cDNA replicates were made from each RNA sam-
ple. Briefly, 0.5 mL ImProm-II reverse transcriptase (Prom-
ega), 0.25 mg 1:3 OligodT/Random primers, 2 ml ImProm-
II buffer, 10 units RNasin Ribonuclease inhibitor (Prom-
ega), 2.5 mM MgCl2 and 2 mM dNTP were mixed with
500 ng of RNA in a 10 mL reaction volume. Reactions
were incubated for 5 min at room temperature, 1 h at
42 C and 15 min at 70 C. Two negative controls were
made without reverse transcriptase added. The cDNA sam-
ples were diluted 1:16 before quantitative real-time PCR
(qPCR) and stored at 80 C until use.| No. 3 | 211–221 213
Figure 2 Selected blood biochemistry data (mean + SEM) from the four different groups after 8 weeks of diet feeding: chow (n = 5), FFC (n = 5),
CDAHFD-S (n = 4), and CDAHFD-F (n = 3). Asterisks indicate statistically significant difference to chow with *P < 0.05, **P < 0.01, and
***P < 0.001. ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyltransferase; GLDH, gluta-
mate dehydrogenase; TG, triglycerides; CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with sucrose; CDAHFD-F, choline-deficient,
amino acid–defined high-fat diet with fructose; FFC, high fat, fructose, and cholesterol.
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metabolism and of four reference genes selected based on
stable expression22 were analyzed in the study (Table S1).
Primers were designed using the tool “Pick Primers” in
PubMed to amplify a product in the range of 100 nucleo-
tides, and if possible, were designed to span a large intron.
High-throughput qPCR was performed on the Biomark
HD system (Fluidigm Corporation) using a 96.96 IFC chip.
Fifteen cycles preamplification using TaqMan PreAmp
Master Mix (Life Technologies), subsequent cleanup with
Exonuclease I (New England BioLabs) and qPCR were per-
formed according to the Fluidigm protocol using Sso-
FastTM EvaGreen Supermix with Low ROX (Bio-Rad
Laboratories). Standard curves were performed using a
pool of the preamplified cDNA. Data were extracted using
the associated software.Statistical methods
Group comparisons were made by one-way ANOVA for
BW, liver weight, blood values, and liver biochemistry
data (with Tukey's or Dunnett's multiple comparisons214 © 2019 Indian National Association for Study of the Liver. Published bytests), by Welch's t-test for morphometric data, and by
Mann–Whitney test for gene expression data. qPCR data
were preprocessed using GenEx software (MultiD,
G€oteborg, Sweden). Briefly, data were corrected for PCR ef-
ficiency and normalized to reference genes (ACTB, GAPDH,
RPL4, TBP1). The cDNA replicates were averaged, and Cq
values were converted into fold changes relative to the sam-
ple with the highest Cq value for each assay, and log2 trans-
formed before statistical analysis. Graphs and statistical
tests were made in GraphPad Prism (version 7.04, Graph-
Pad Software Inc., La Jolla, CA, USA). Data are shown as
mean SEM and the significance level was P < 0.05, unless
otherwise noted.RESULTS
Body weight and liver weight
The CDAHFD-S group had statistically significantly lower
BW at study-end compared with the chow group (P = 0.01).
The CDAHFD-F group showed a similar trend (P = 0.08),
whereas the FFC group tended to have a higher BW
(P = 0.10; Figure 1A).Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1 Hematological and Blood Biochemical Parameters.
Parameter Chow FFC CDAHFD-S CDAHFD-F
Leucocytes (109/L) 9.9  1.0 17.2  2.6 12.7  1.8 13.0  2.1
Erythrocytes (1012/L) 8.7  0.3 7.6  0.2 6.0  0.7** 6.7  0.5*
Hemoglobin (mmol/L) 7.9  0.3 6.5  0.3 6.0  0.6* 6.4  0.6
Hematocrit (%) 42  2 35  2 30  3* 34  4
Thrombocytes (109/L) 284  80 392  48 207  67 199  98
Neutrophils (109/L) 1.6  0.4 3.6  0.6 3.4  0.5 4.9  1.0**
Lymphocytes (109/L) 7.4  0.7 11.2  1.5 7.7  1.2 6.4  1.1
Monocytes (109/L) 0.28  0.06 0.79  0.22 0.57  0.21 0.52  0.10
Eosinophils (109/L) 0.51  0.22 1.24  0.36 0.78  0.16 0.87  0.14
Basophils (109/L) 0.03  0.01 0.05  0.01 0.02  0.01 0.03  0.01
Reticulocytes (109/L) 128  10 123  16 389  122* 275  52
Creatine kinase (U/L) 243  30 452  204 715  431 289  29
Total bilirubin (mmol/L) 0.0  0.0 1.2  0.4 6.0  1.7** 2.0  1.5
Urea (mmol/L) 3.0  0.2 2.8  0.3 4.2  0.4* 3.8  0.1
Creatinine (mmol/L) 91.0  4.4 69.2  4.1** 51.8  4.6*** 56.0  5.6***
Albumin (g/L) 40.6  1.7 39.8  1.1 41.3  1.1 44.0  1.8
Total protein (g/L) 54.9  1.0 59.5  1.5 57.2  1.2 61.4  1.5*
Iron (mmol/L) 42.3  6.7 30.6  2.6 30.4  3.0 26.5  5.6
Phosphate (mmol/L) 2.34  0.06 2.82  0.08*** 2.68  0.03** 2.87  0.03***
Calcium (mmol/L) 2.86  0.06 2.77  0.07 2.88  0.08 2.93  0.03
Magnesium (mmol/L) 1.03  0.03 1.01  0.06 0.96  0.02 1.02  0.05
Sodium (mmol/L) 146.7  0.9 143.4  2.1 142.7  1.3 144.7  0.8
Potassium (mmol/L) 4.8  0.3 4.9  0.2 5.3  0.2 5.8  0.2
Globulin (g/L) 14.3  0.8 19.7  0.7*** 15.8  0.6 17.4  1.0
Fructosamine (mmol/L) 228  4 238  12 245  6 242  5
Glucose (mmol/L) 4.9  0.3 4.3  0.3 4.6  0.3 5.4  0.8
Data are mean  SEM. *P < 0.05 vs chow, **P < 0.01 vs chow, ***P < 0.001 vs chow.
CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with sucrose; CDAHFD-F, choline-deficient, amino acid–defined high-fat diet with fruc-
tose; FFC, high fat, fructose, and cholesterol.
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DCompared with the chow group, the liver was large and
pale in all minipigs from the three NASH groups
(Figure 1B) and weighed more (chow 162  12 g; FFC
402  42 g; CDAHFD-S 381  26 g; CDAHFD-F
405  31 g; all P < 0.001; Figure 1C). Compared with a
mean relative liver weight of 19.2 g/kg in the chow group,
that of the FFC group was increased 2.1-fold (41.1 g/kg),
the CDAHFD-S group 3.1-fold (59.9 g/kg), and the
CDAHFD-F group 3.1-fold (59.0 g/kg), as shown in
Figure 1D. One minipig in the CDAHFD-F group had sub-
dued behavior and inappetence two weeks before study-
end and was euthanized for ethical reasons. At necropsy,
the gastrointestinal system of this pig showed signs of
ileus. The liver gross and histological appearance and
weight was like the other CDAHFD-F minipigs (data not
shown). No study-end data from this minipig were
included in any analyses. Splenomegaly with a pale appear-Journal of Clinical and Experimental Hepatology | May–June 2020 | Vol. 10ance was found in all animals in the FFC group (Fig. S1).
Histologically, an accumulation of foamy macrophage-
like cells was seen in these spleens (Fig. S2).Hematological and biochemical blood tests
Except from alanine transaminase, all other biomarkers of
liver damage (AST, aspartate transaminase; ALP, alkaline
phosphatase; GGT, gamma-glutamyltransferase and
GLDH glutamate dehydrogenase) were increased in all
three NASH groups, albeit not statically significantly in
all cases (Figure 2). The markers of dyslipidemia (triglycer-
ide and cholesterol) were increased in all the NASH groups,
albeit only statistically significantly in the FFC group.
Neither blood glucose (Table 1) nor plasma insulin levels
changed significantly over the course of 8 weeks, whereas
plasma glucagon was significantly increased in the| No. 3 | 211–221 215
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FLDCDAHFD-S group and showed a similar trend in the other
two NASH groups.
With regard to other blood parameters, the CDAHFD-S
group had decreased erythrocytes, hemoglobin, and he-
matocrit, and increased reticulocytes, suggestive of mild
regenerative anemia (Table 1). The FFC group had elevated
globulin levels, the CDAHFD-F group had elevated num-
ber of neutrophils, and all three NASH groups had elevated
plasma phosphate concentrations and decreased plasma
creatinine concentrations (Table 1). The remaining param-
eters were not significantly altered by diet.
Biochemical analyses of liver tissue
The triglyceride content in the liver of the minipigs was
similar in the chow and FFC group, but it was markedly
increased in the two CDAHFD groups—a change that
was seen already in the 2-week samples (Figure 3). The
cholesterol content in the liver was significantly increased
in all three NASH groups already after 2 weeks, and re-
mained high after 8 weeks, although not statistically signif-
icant in the FFC group (P = 0.08).
Histology
Based on HE staining, pronounced steatosis was observed
throughout the parenchyma in both CDAHFD groups,Figure 3 Content of triglycerides (TG; upper panels) and total cholesterol (low
with chow (n = 5), FFC (n = 5), CDAHFD-S (n = 4), and CDAHFD-F (n = 3). Da
different from chow with *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.00
sucrose; CDAHFD-F, choline-deficient, amino acid–defined high-fat diet wit
216 © 2019 Indian National Association for Study of the Liver. Published bywith markedly larger lipid droplets after 8 weeks than after
2 weeks (Figure 4). When quantified by morphometry, the
two CDAHFD groups showed increased hepatic steatosis
already at week 2 which was further augmented at week
8, with no difference between CDAHFD-S and
CDAHFD-F (Figure 5A and B). Hepatic steatosis was not
present in the FFC group, but “foamy” macrophage-like
cells lining the sinusoids were noticed (Figures 4, 5A and
B). No evidence of ballooning degeneration was observed
in any of the minipigs.
Lobular inflammatory foci were observed in the 2- and 8-
week liver samples from both CDAHFD groups, but not in
the FFC group (Figure 4A and B). CD45 is a marker for leu-
kocytes and immunohistochemical staining confirmed the
presence of both resident Kupffer cells and patrolling im-
mune cells in livers from chow animals (Figure 4B).
Morphologically, crown-like structures around single, fatty
hepatocytes were present in the CDAHFD groups, indi-
cating the presence of microgranulomas (Figure 4B). These
structures were not observed in the FFC group, in which si-
nusoidal foamy macrophage-like cells were seen instead
(Figure 4A and B). Morphometric quantification showed
significantly increased CD45 staining in all three NASH
groups compared with chow (Figure 5C).
Activation of hepatic stellate cells was visualized in 8-
week samples by SMA immunohistochemistry. In bother panels) in liver samples taken after two and eight weeks of diet feeding
ta are shown as mean + SEM. Asterisks indicate statistically significantly
01. CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with
h fructose; FFC, high fat, fructose, and cholesterol.
Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 4 Histological analyses of liver samples from G€ottingen Minipigs after 2 (A) and 8 (B, C) weeks of feeding with the indicated diets: chow, FFC,
CDAHFD-S, and CDAHFD-F. Representative pictures show HE staining (upper panels in A, B, C), immunohistochemistry for CD45 and SMA (middle
panels in B) and sirius red staining (lower panels in B, C). Arrows, arrow heads, and asterisks indicate sinusoidal foamy macrophages, inflammatory
foci, and crown-like structures, respectively. Scale bars = 100 mm (A, B) and 1mm (C). CDAHFD-S, choline-deficient, amino acid–defined high-fat diet
with sucrose; CDAHFD-F, choline-deficient, amino acid–defined high-fat diet with fructose; FFC, high fat, fructose, and cholesterol; CD45, cluster of
differentiation 45; SMA, smooth muscle actin.
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sinusoidally, in between, and surrounding steatotic hepa-
tocytes (Figure 4B). When quantified by morphometry,
SMA stained area was statistically significantly higher in
the two CDAHFD groups than in the chow and FFC
groups (Figure 5D). SMA area was increased only weaklyJournal of Clinical and Experimental Hepatology | May–June 2020 | Vol. 10in the FFC group compared with chow and localized peri-
sinusoidally like the SMA-positive cells in the chow group
(Figures 4B and 5D).
Fibrosis assessed morphometrically from sirius red
stained samples was statistically significantly increased in
both CDAHFD groups compared with chow, whereas no| No. 3 | 211–221 217
Figure 5 Morphometric assessment of steatosis (A, B), CD45 (C), smooth muscle actin (SMA) (D), and sirius red (E) staining in livers from G€ottingen
Minipigs after 2 (A) and 8 (B–E) weeks of feeding with different diets: chow (n = 5), FFC (n = 5), CDAHFD-S (n = 4), and CDAHFD-F (n = 3). Data are
shown as mean + SEM. * and #P < 0.05 vs chow and FFC, respectively, ** and ##P < 0.01 vs chow and FFC, respectively, *** and ###P < 0.001 vs
chow and FFC, respectively. CD45, cluster of differentiation 45; CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with sucrose;
CDAHFD-F, choline-deficient, amino acid–defined high-fat diet with fructose; FFC, high fat, fructose, and cholesterol.
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A
FLDincrease was observed in the FFC group (Figure 5E). The
fibrotic tissue in the CDAHFD groups formed a chicken-
wire pattern around steatotic hepatocytes mirroring the
localization of SMA+ cells (Figure 4B). In contrast to hu-
man livers, porcine liver lobules are surrounded by distinct
collagen septae which appeared unchanged in all three
NASH groups compared with chow (Figure 4C).Gene expression
When compared with the chow group, many genes showed
statistically significantly different expression in the three
NASH groups (Tables S2 and S3 and Figure 6), especially
at the 8-week time point. Figure 6A shows expression of
genes involved in de novo fibrogenesis (COL1A1,
COL3A1); reorganization of extracellular matrix (MMP9,
TIMP1); and stellate cell activation (ACTA2) after 8 weeks.
The expression of COL1A1 and COL3A1 was significantly
increased in the two CDAHFD groups, and the expression218 © 2019 Indian National Association for Study of the Liver. Published byofMMP9 and TIMP1 was significantly increased in all three
NASH groups. ACTA2 was significantly upregulated in the
CDAHFD-F group and showed a similar tendency in the
CDAHFD-S group (P = 0.06).
Figure 6B represents genes encoding proteins associated
with inflammation, such as cytokines (CCL2, IL6, and
TNFA), TLR4, and CD68 (a marker of macrophages and
Kupffer cells). Overall, these genes had significantly
increased expression in all three NASH groups compared
with the chow group.
Figure 6C illustrates genes encoding proteins involved
in lipid, bile, and cholesterol metabolism. All three
NASH groups had significantly increased expression of
CD36, CYP7A1, and LPL; and significantly decreased
expression of HMGCR, LDLR, and PCSK9. The NASH
groups differed markedly regarding FABP4 gene expres-
sion, which was unaltered in the FFC group but signifi-
cantly increased in the two CDAHFD groups (see also
Table S2).Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 6 Hepatic mRNA levels for genes associated with fibrosis (A), inflammation (B), and lipid metabolism (C) after 8 weeks of feeding G€ottingen
Minipigs with different diets: chow (n = 5), FFC (n = 5), CDAHFD-S (n = 4), and CDAHFD-F (n = 3). The data were normalized to a panel of four stable
reference genes and are represented asmeans + SEMof the fold changes for each diet group. *P < 0.05 vs chow, **P < 0.01 vs chow.ACTA2, smooth
muscle a-2 actin;CCL2, chemokine (C–Cmotif) ligand 2;CD36, cluster of differentiation (CD) 36;CD68, cluster of differentiation 68;COL1A1, alpha-1
type I collagen; COL3A1, alpha-1 type III collagen; CYP7A1, cytochrome P450 family 7 subfamily A member 1; FABP4, fatty acid–binding protein 4;
HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; IL6, interleukin-6; LDLR, low-density lipoprotein receptor; LPL, lipoprotein lipase;MMP9,matrix
metalloproteinase-9; PCSK9, proprotein convertase subtilisin/kexin type 9; TIMP1,metalloproteinase inhibitor 1; TLR4, toll-like receptor 4; TNFA, tu-
mor necrosis factor alpha; CDAHFD-S, choline-deficient, amino acid–defined high-fat diet with sucrose; CDAHFD-F, choline-deficient, amino acid–
defined high-fat diet with fructose; FFC, high fat, fructose, and cholesterol.
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G€ottingen Minipigs fed CDAHFD for 8 weeks developed
widespread and pronounced hepatic steatosis with lobular
inflammatory foci, activated stellate cells, increased expres-
sion of profibrotic genes, and fibrosis in a chicken-wire
pattern associated with steatotic hepatocytes. In line with
other minipig studies, FFC diet did not cause significant
steatosis after 8 weeks, at which time point inflammation
was dominated by foamy macrophage-like cells.Journal of Clinical and Experimental Hepatology | May–June 2020 | Vol. 10The low variation within the CDAHFD groups in the
present study indicates a more robust and reproducible
model than that described in previous studies with FFC
diet. It appears that the content of methionine and lipids
was optimal in the CDAHFD diets, as it was possible to
obtain a growth rate on par with that in the chow group
in the last half of the study (after addition of flavor to
the diet). Although the minipigs on CDAHFD were not
obese, their plasma triglyceride and cholesterol levels
were slightly elevated. Despite the changes in diet| No. 3 | 211–221 219
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FLDcomposition, however, none of the NASH groups showed
signs of significant insulin resistance, as they all had
normal levels of glucose and fructosamine (a measure of
long-term glucose levels), and low-to-normal insulin levels.
The low creatinine concentrations in all NASH groups
probably reflect impaired liver function.23 Among the
circulating liver damage markers, ALP and GLDH were
the most consistently increased in the NASH groups, and
thus show some potential as biomarkers.
Pronounced macrovesicular steatosis was established
already after 2 weeks on CDAHFD and was even more
manifest after 8 weeks. Choline deficiency induces steatosis
by impairing hepatic Very Low Density Lipoproteins
(VLDL) export. The FFC group did not display appreciable
steatosis—in agreement with long-term studies with a
similar diet.7–9 Species differences in localization of de
novo lipogenesis might contribute to this.6 Thus, FFC di-
ets (or similar) will not cause marked steatosis (and
steatosis-driven inflammation and fibrosis) in pigs. Howev-
er, we observed foamy macrophage-like cells in both liver
and spleen of the minipigs in the FFC group, as previously
reported.11 Increased gene expression of FABP4, CD36, and
LPL indicates increased fatty acid uptake, transport, and
metabolism in the NASH groups, and the fact that
FABP4 only showed a statistically significantly increased
expression in the two CDAHFD groups reflects that only
these groups had hepatic steatosis. The dietary cholesterol
repressed the endogenous cholesterol synthesis (reduced
HMGCR), increased the cholesterol metabolism (increased
CYP7A1), and increased the hepatic uptake of circulating
cholesterol (reduced PCSK9) in all the NASH groups.
Foci of inflammatory cells were seen already after 2
weeks in the CDAHFD groups. The morphometric CD45
immunohistochemistry data showed that all NASH
groups had an increased number of inflammatory cells
compared with the chow group after both 2 and 8 weeks.
These cells were localized sinusoidally in the FFC group,
presumably representing foamy macrophages, whereas
they formed crown-like structures around steatotic hepa-
tocytes in the two CDAHFD groups. Such crown-like
structures are seen in mouse models and in humans with
NASH and are suggested to be an important indicator of
disease progression from simple steatosis to NASH.24 In
line with the histology findings, the expression of CD68
was increased in all NASH groups, supporting recruitment
of proinflammatory monocytes/macrophages and/or acti-
vation of resident Kupffer cells.
Histologically, fibrosis as evaluated by sirius red stain-
ing was present in the CDAHFD groups after 8 weeks
forming a chicken-wire pattern associated with steatotic
hepatocytes. When quantified by morphometry, sirius
red data showed significantly increased fibrosis in the
CDAHFD groups. In accordance with this, quantitative
analysis of IHC staining for SMA, a marker of fibrinogenic
myofibroblast such as activated stellate cells, showed220 © 2019 Indian National Association for Study of the Liver. Published byincreased levels in the NASH groups and especially so in
the two CDAHFD groups and, moreover, the gene expres-
sion analyses showed that genes associated with fibrosis
were expressed at higher levels in these groups and less
so in the FFC group. The importance of these genes in hu-
man NASH was recently shown.4,25–27 The CDAHFD
groups thus showed more evidence of ongoing
profibrotic processes, and in addition, the fibrosis
appeared to be driven by the steatotic hepatocytes like in
humans.
Fibrosis was recently found to be the only histological
feature with prognostic importance in human NAFLD,2
and a number of pharmaceutical companies are pursuing
antifibrotic targets.3,4 In that connection, a G€ottingen
Minipig NASH model based on CDAHFD could be valu-
able. Notably, the minipig has a more human-like meta-
bolism, lipid profile, and inflammasome5 than rodents—
as well as a size allowing repeated tissue and blood sam-
pling. The level of fibrosis seen already at 8 weeks of diet
feeding gives hope that the model over time could develop
true bridging fibrosis, which typically cannot be obtained
in steatosis-driven steatohepatitis in mice. It appears that
several months will be needed for severe fibrosis to develop,
and this is a disadvantage of the model. However, signifi-
cant information about disease development can be gained
early on by following disease markers such as gene expres-
sion patterns.
The sugar source did not significantly influence the find-
ings in the CDAHFD groups in this study. In mice, fructose
leads to more hepatic fatty acid synthesis and cytotoxicity
than glucose.14,15 In humans, the evidence of harmful ef-
fects of fructose, in isocaloric amounts, is less clear.16,17
G€ottingen Minipigs fed CDAHFD for 8 weeks devel-
oped pronounced steatosis with inflammation and fibrosis
associated with steatotic hepatocytes. In concert with pre-
vious minipig studies, FFC diet did not produce steatosis
and there was no significant fibrosis. The CDAHFD diets
described here show promise as a basis for a minipig
NASH model with human-like dyslipidemia and hence
with high translational value. Long-term studies are war-
ranted to show the period needed for marked fibrosis to
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